Regeneron: Trial COVID-19 drug cocktail cut virus load in more people

[perugu_vada]

Shares of Regeneron Pharmaceuticals Inc. (REGN) rose more than 3% in the extended session Wednesday after the company said its experimental antibody cocktail "significantly reduced" novel-coronavirus levels and the need for "further medical attention," including hospitalizations and emergency-room visits, in more people enrolled in its ongoing late-stage trial.
 

Regeneron, which earlier this month said it had submitted a request for emergency authorization to the Food and Drug Administration for the experimental antibody treatment, said it had shared the new information with the FDA.

[BeerBob123]

Ticker please

[Spartan]

tata ide veskunnad kada.  anduke 2 days lo baitakochadu